Your browser doesn't support javascript.
loading
Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.
Caprnda, Martin; Kubatka, Peter; Gazdikova, Katarina; Gasparova, Iveta; Valentova, Vanda; Stollarova, Nadezda; La Rocca, Giampiero; Kobyliak, Nazarii; Dragasek, Jozef; Mozos, Ioana; Prosecky, Robert; Siniscalco, Dario; Büsselberg, Dietrich; Rodrigo, Luis; Kruzliak, Peter.
Afiliação
  • Caprnda M; 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
  • Kubatka P; Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia; Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
  • Gazdikova K; Department of Nutrition, Faculty of Nursing and Professional Health Studies, Slovak Medical University, Bratislava, Slovakia; Department of General Medicine, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia. Electronic address: katarina.gazdikova@szu.sk.
  • Gasparova I; Institute of Biology, Genetics and Medical Genetics, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
  • Valentova V; Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
  • Stollarova N; Catholic University in Ruzomberok, Faculty of Pedagogy, Department of Biology and Ecology, Ruzomberok, Slovakia.
  • La Rocca G; Human Anatomy Section, Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo and Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy.
  • Kobyliak N; Endocrinology Department, Bogomolets National Medical University, Kyiv, Ukraine.
  • Dragasek J; 1st Department of Psychiatry, Faculty of Medicine, Pavol Jozef Safarik University and University Hospital, Kosice, Slovakia.
  • Mozos I; Department of Functional Sciences, Discipline of Pathophysiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
  • Prosecky R; Department of Internal Medicine, Merciful Brothers Hospital, Brno, Czech Republic.
  • Siniscalco D; Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Büsselberg D; Weill Cornell Medical College in Qatar, Qatar Foundation - Education City, Doha, Qatar.
  • Rodrigo L; University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
  • Kruzliak P; Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic; 2nd Department of Surgery, Faculty of Medicine,St. Annés University Hospital, Brno, Czech Republic. Electronic address: kruzliakpeter@gmail.com.
Biomed Pharmacother ; 91: 60-69, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28448871
ABSTRACT
Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco / Doenças Neurodegenerativas / Transplante de Células-Tronco / Fatores Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Eslováquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco / Doenças Neurodegenerativas / Transplante de Células-Tronco / Fatores Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Eslováquia